BNP PARIBAS FINANCIAL MARKETS - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 348 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q2 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$12,299
-71.8%
795
-71.4%
0.00%
Q2 2023$43,690
+31.1%
2,781
+37.5%
0.00%
Q1 2023$33,323
+122.5%
2,022
+110.6%
0.00%
Q4 2022$14,976
-99.9%
9600.0%0.00%
Q3 2022$12,451,000
-76.4%
960
-74.5%
0.00%
Q2 2022$52,847,000
-96.1%
3,764
-96.0%
0.00%
-100.0%
Q1 2022$1,351,479,000
-63.7%
94,377
-65.4%
0.00%
-60.0%
Q4 2021$3,721,017,000
+428.0%
273,002
+534.5%
0.01%
+400.0%
Q3 2021$704,733,000
-0.6%
43,024
+2.1%
0.00%0.0%
Q2 2021$709,149,000
-87.0%
42,136
-83.7%
0.00%
-87.5%
Q1 2021$5,450,427,000
-10.0%
258,296
-22.4%
0.01%
-27.3%
Q4 2020$6,058,598,000
+9.1%
332,890
+7.0%
0.01%
+37.5%
Q3 2020$5,552,022,000
-9.3%
311,212
-8.8%
0.01%
-27.3%
Q2 2020$6,121,212,000
+21.1%
341,395
+2.6%
0.01%
+10.0%
Q1 2020$5,052,754,000
-19.7%
332,856
+4.3%
0.01%
-9.1%
Q4 2019$6,294,245,000
+16.6%
319,019
+1.6%
0.01%
+10.0%
Q3 2019$5,400,026,000
-4.9%
313,955
-2.1%
0.01%
-9.1%
Q2 2019$5,676,124,000320,6850.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q2 2019
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,584,930$138,046,00026.79%
Glenview Capital Management 15,260,512$277,741,0006.37%
Paulson & Co. 11,295,846$205,584,0005.34%
GMT CAPITAL CORP 2,871,395$52,259,0003.72%
MANAGED ASSET PORTFOLIOS, LLC 966,643$17,593,0003.09%
TFG Asset Management GP Ltd 1,443,052$26,264,0001.76%
Mondrian Investment Partners LTD 3,274,660$58,944,0001.46%
Blackcrane Capital, LLC 35,236$641,0001.26%
Lumbard & Kellner, LLC 136,378$2,404,0000.95%
DAVIDSON INVESTMENT ADVISORS 509,800$9,278,0000.86%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders